Kazia Therapeutics Health Care
Cancer Medical

$0.160 -0.005 (-3.03%)

High $0.16	Low $0.16	Trades 13	Turnover $11,013	Volume 68,980
30 June 2023 at 12:18pm

Market Cap (15-Nov) $18,907,918 (738th)	Close (30-Jun) $0.160 0 (0%)	Volume (30-Jun) 68,980	Shortsold (1-Nov) 1 (0.00%) (657th)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.11

Short Interest

ASIC data, 1 Nov 2023

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

657th

of 710 shorted ASX stocks

Peak Short

0.96%

Mar 2020

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	KZA KZA Ann: Appendix 2A
	1 (current) 2 3
	KZA KZA Ann: Kazia licenses Cantrixil to Oasmia
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Proposed issue of Securities - KZA
	KZA KZA Ann: Kazia half year accounts and Appx 4D
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Appendix 4C - quarterly
	KZA KZA Ann: Kazia presents to ShareCafe Hidden Gems webinar
	KZA KZA Ann: Kazia commences recruitment to GBM AGILE
	KZA KZA Ann: Kazia presents to HCW BIOCONNECT
	KZA KZA Ann: Appendix 3G Issue of staff options
	KZA KZA Ann: Change in directors interest
	KZA KZA Ann: Change in directors interests
	KZA KZA Ann: Change in directors interests
	KZA KZA Ann: Kazia receives $1.02m R&D cash rebate
	KZA KZA Ann: Kazia presents to LD Micro Main Event
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: paxalisib PNOC collaboration
	KZA KZA Ann: Kazia releases Cantrixil top line final data
	KZA KZA Ann: Kazia presentation to Bell Potter Healthcare Conference
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Kazia investor briefing transcript
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Kazia's paxalisib SNO data
	KZA KZA Ann: Kazia presents to HCW Israel conference
	KZA KZA Ann: Change in directors interests * 4
	KZA KZA Ann: Kazia issue of options
	KZA KZA Ann: Kazia Results of Annual General Meeting
	KZA KZA Ann: Kazia AGM materials
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Kazia unmarketable parcel share sale facility
	KZA KZA Ann: Quarterly Activities Report and Appendix 4C
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Becoming a substantial holder
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Kazia Appendix 2A retail offer
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Kazia Completion of Retail Offer
	KZA KZA Ann: Kazia executes GBM Agile study agreement

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
15-Nov	$0.08	0	0.00 (0.00%)
14-Nov	$0.08	0	0.00 (0.00%)
13-Nov	$0.08	454,181	+0.01 (9.59%)
10-Nov	$0.07	1,958,419	-0.01 (16.09%)
09-Nov	$0.09	2,428,685	-0.02 (20.91%)
08-Nov	$0.11	1,035,042	+0.03 (37.50%)
07-Nov	$0.08	489,091	+0.01 (19.40%)
06-Nov	$0.07	1,622,414	+0.01 (21.82%)
03-Nov	$0.06	938,181	0.00 (0.00%)
02-Nov	$0.06	1,610,003	-0.01 (9.84%)
01-Nov	$0.06	742,258	-0.01 (12.86%)
31-Oct	$0.07	1,267,882	-0.01 (12.50%)
30-Oct	$0.08	732,079	-0.01 (5.88%)
27-Oct	$0.09	596,210	0.00 (4.49%)
26-Oct	$0.09	399,238	0.00 (1.11%)
4 up, 8 down, and 3 flat days

Kazia Therapeutics Health Care
Cancer Medical

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

KZA Kazia Therapeutics Health Care Cancer Medical

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Kazia Therapeutics Health Care
Cancer Medical